» Authors » Y Sturm

Y Sturm

Explore the profile of Y Sturm including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, et al.
Neurology . 2006 Aug; 67(4):679-82. PMID: 16924022
The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label...
2.
Pina-Garza J, Espinoza R, Nordli D, Bennett D, Spirito S, Stites T, et al.
Neurology . 2005 Nov; 65(9):1370-5. PMID: 16275822
Objective: To evaluate the efficacy, safety, and pharmacokinetics of oxcarbazepine as adjunctive therapy in infants and young children (1 month to < 4 years). Methods: Children 1 month to <...
3.
Barcs G, Walker E, Elger C, Scaramelli A, Stefan H, Sturm Y, et al.
Epilepsia . 2000 Dec; 41(12):1597-607. PMID: 11114219
Purpose: The goal of the study was to evaluate the safety and efficacy of a broad oxcarbazepine (OXC) dosage range (600, 1200, and 2400 mg/d) as adjunctive therapy for uncontrolled...
4.
Fattore C, Cipolla G, Gatti G, Limido G, Sturm Y, Bernasconi C, et al.
Epilepsia . 1999 Jun; 40(6):783-7. PMID: 10368079
Purpose: To evaluate the effect of oxcarbazepine (OCBZ) on the pharmacokinetic profile of steroid oral contraceptives. Methods: Twenty-two healthy women aged 18-44 years were recruited, and 16 of them completed...
5.
Volz H, Muller H, Sturm Y, Preussler B, Moller H
Psychiatry Res . 1995 Sep; 58(2):107-15. PMID: 8570762
Most findings of antidepressant treatment prediction have not been replicated, and this applies to biological predictors as well as sociodemographic and early course predictors. One exception might be early psychopathological...
6.
Volz H, Sturm Y
Neuropsychobiology . 1995 Jan; 31(3):146-55. PMID: 7609863
Nearly all antidepressants are tested psychometrically in order to detect side effects of these drugs. Based on a review of the relevant published data on critical flicker fusion frequency measurements,...
7.
Beermann D, Schaefer H, Wargenau M, Heibel B, Sturm Y, Kuhlmann J
Eur J Clin Pharmacol . 1992 Jan; 42(3):307-12. PMID: 1315685
The pharmacokinetics of BAY w 8199, the active metabolite of the prodrug repirinast (BAY u 2372), has been investigated after oral administration of 150, 300 and 450 mg repirinast to...
8.
Sturm Y
Z Klin Psychol Psychopathol Psychother . 1986 Jan; 34(3):196-204. PMID: 3577294
No abstract available.